2,3,5,6-Tetramethylcyclohexa-2,5-diene-1,4-dione

Introduction

CAS No. :	527-17-3	MDL No. :	MFCD00001604
Formula :	C10H12O2	Boiling Point :	-
Linear Structure Formula :	C6(CH3)4O2	InChI Key :	WAMKWBHYPYBEJY-UHFFFAOYSA-N
M.W :	164.20	Pubchem ID :	68238
Synonyms :

Physicochemical Properties

Num. heavy atoms :	12
Num. arom. heavy atoms :	0
Fraction Csp3 :	0.4
Num. rotatable bonds :	0
Num. H-bond acceptors :	2.0
Num. H-bond donors :	0.0
Molar Refractivity :	47.52
TPSA :	34.14 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	No
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-5.72 cm/s

Lipophilicity

Log Po/w (iLOGP) :	2.06
Log Po/w (XLOGP3) :	2.23
Log Po/w (WLOGP) :	1.81
Log Po/w (MLOGP) :	1.08
Log Po/w (SILICOS-IT) :	2.7
Consensus Log Po/w :	1.98

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	1.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-2.26
Solubility :	0.896 mg/ml ; 0.00546 mol/l
Class :	Soluble
Log S (Ali) :	-2.58
Solubility :	0.43 mg/ml ; 0.00262 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-2.81
Solubility :	0.257 mg/ml ; 0.00157 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	1.0 alert
Brenk :	1.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	2.91

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine